1 Autoradiographic studies were conducted to investigate the receptor subtypes for endothelin-I that were present in the ovine respiratory tract. In addition, the receptor subtypes mediating contraction of airway smooth muscle and the possible involvement of extracellular Ca2" and inositol phosphate generation in intracellular signal transduction were assessed.
Introduction
It is now established that both ETA and ETB receptors can receptors, which are selectively stimulated by sarafotoxin S6c mediate endothelin-1 (ET-1)-induced contraction of airway and BQ 3020 (Williams et al., 1991; Ihara et al., 1992b) .
smooth muscle (Hay, 1992; Henry, 1993) . ET-1-induced con-ET-1-induced stimulation of these receptors appears to be traction of guinea-pig tracheal smooth muscle (Tschirhart et linked to the activation of the inositol phosphate cascade al., 1991; Hay, 1992 ) is mediated predominantly via ETB (Hay, 1990) , and thus presumably to the mobilization of intracellular Ca2l stores. In contrast, it has been suggested Author for correspondence.
that in sheep airways, the ETA receptor subtype predom-'." Macmillan Press Ltd, 1994 inates (Araham et al., 1993) . This is consistent with data showing that the ETA receptor-selective antagonist, BQ 123 (Ihara et al., 1992a) markedly attenuated ET-1-induced bronchoconstriction in allergic sheep and of contraction of tracheal smooth muscle isolated from such animals (Noguchi et al., 1992) . In contrast, in rat trachea, powerful contraction was mediated via both ETA receptors linked to inositol phosphate generation and ETB receptors which facilitated the influx of extracellular Ca2+ (Henry, 1993) . In the present study, we assessed the autoradiographic distribution and density of both ETA and ETB receptors in ovine tracheal smooth muscle and evaluated their role in ET-1-induced contraction and in the generation of intracellular inositol phosphates.
Methods Tissue preparation
Sheep tracheal and lung parenchymal tissue was obtained at a local abattoir from freshly slaughtered lambs 4-9 months of age. Tissue was transferred to the laboratory in ice-cold Krebs bicarbonate solution, the composition of which was (mM): NaCl 117, KC1 5.36, NaHCO3 25.0, KH2PO4 1.03, MgSO4.7H2O 0.57, CaCl2.H2O 2.5 and glucose 11.1. Surrounding fat and other adherring tissue was removed from the trachea and a longitudinal cut was made through the cartilage down the length of the airway opposite the smooth muscle band. Tissue containing the smooth muscle was removed with the epithelium and some cartilage still attached. These preparations were then submerged in Macrodex and frozen by immersion in isopentane, quenched with liquid nitrogen. In addition, tracheal smooth muscle dissected free of all epithelium, submucosal tissue and cartilage, was obtained from six sheep and a piece (approx. 10 mm x 10 mm) from each animal stacked in layers in Macrodex and frozen as described above. Transverse sections (10 jm) of all preparations were cut at -20'C and thaw-mounted onto gelatin/chrome alum-coated glass slides. Parenchymal tissue was inflated by bronchial instillation with OCT embedding medium diluted 1:4 with 0.9% w/v NaCl solution before snap freezing, sectioning and thaw-mounting on glass slides as described above.
Autoradiographic studies [I25l-ET-l autoradiographic studies in sheep tracheal and lung parenchymal tissue were conducted essentially as previously described for other species (Henry et al., 1990) .
Slide-mounted tissue sections (10 ,Am) were incubated for 2 x 10 min at 22°C in Tris-HCl buffer (50 mM Tris, 100 mM NaCl; pH 7.4) containing 0.25% (w/v) bovine serum albumin and the protease inhibitor phenylmethylsulphonyl fluoride (10 gM). For some autoradiographic experiments, tissue sections were incubated with 0.5 nM ['25Il-ET-1 for 60 min in the presence and absence of the ETA receptor-selective antagonist, BQ 123 (1 gM) or the ETB receptor-selective agonist, sarafotoxin S6c (100nM). Non-specific binding was determined in the combined presence of 1 LM BQ 123 and 100 nM sarafotoxin S6c. Autoradiographic grain densities over alveolar wall tissue were determined with an automated grain detection and counting system (Henry et al., 1990 Functional studies Trachea Sheep trachea was cut transversely at intervals of approximately 3 mm to provide a series of ring segments. The epithelium and attached submucosa was dissected away from the smooth muscle band. The exterior connective tissue and other deep submucosal elements were also dissected from the preparation to leave the intact airway smooth muscle stretched across the cartilage ring as a thin band. This muscle was trimmed to leave a fine filament. Two ligatures approximately 5 mm apart were tied around this muscle filament to provide points of attachment to anchorage sites in the organ bath system. Tracheal preparations were suspended under a resting tension of 500 mg and placed in organ baths containing 2 ml of Krebs bicarbonate solution of 37°C, bubbled continuously with 5% CO2 in 02 Changes in isometric tension were recorded via FT03 force-displacement transducers (Grass Instruments).
Tracheal segments were allowed to equilibrate for 45 min before exposure to the cumulative addition of 0.3 fLM and 10 jM carbachol. Upon reaching a contraction plateau the preparations were washed in drug-free Krebs bicarbonate solution for 15 min. Concentration-effect curves were constructed to ET-1 in the presence and absence of the ETA receptor antagonist, BQ 123 (1 ELM), or the cyclo-oxygenase inhibitor, indomethacin (5 rM). In these experiments, preparations were exposed for 20 min to one of these agents or its solvent (paired control preparation) and then to cumulative additions (0.5 log-concentration increments) of ET-l (1 nM to 300 nM). In some experiments, tracheal responsiveness to sarafotoxin S6c or BQ 3020 was also evaluated (1 nM to 300 nM). In a separate series of experiments, the influence of the L-type Ca2" channel antagonist nicardipine (1 LLM) or reducing the extracellular Ca2" concentration nominally to zero was assessed on tracheal smooth muscle contraction to potassium (K+), carbachol and ET-1. In the latter experiments, Krebs bicarbonate solution was replaced three times at intervals of 15 min, with Ca2"-free Krebs bicarbonate solution containing EGTA (0.1 mM). In all experiments, only one agonist cumulative concentration-effect curve was constructed in each preparation. ET-1, BQ 3020-, sarafotoxin S6c-, carbachol-and K+-induced contractions were plotted as a percentage of the initial contraction induced by 10 ILM carbachol (Cma,) . Agonist potencies were assessed as pD2
values where pD2 =-log EC50 and EC50 = the concentration of agonist producing 50% of the maximal response (Emax).
Lung parenchyma strips The marginal edge of the primary lung lobe was cut away as a strip to expose the underlying parenchymal tissue. A strip of parenchyma approximately 2 mm x 2 mm x 6 mm, free of pleural lining tissue, was then dissected from the exposed edge. Such preparations were suspended in organ baths as described for tracheal preparations and their responsiveness to cumulative concentrations of carbachol, ET-1, sarafotoxin S6c or BQ 3020 tested. Contractions were assessed as % of the response to 400 tiM carbachol (Cm,,) . Agonist potencies were assessed as the concentration producing 50% of the contraction to 400 gM carbachol (95% confidence limits).
[3H]-inositol phosphate accumulation
Inositol phosphates accumulation in response to ET-1, sarafotoxin S6c and carbachol were determined as previously described (Henry et al., 1992 
Hay of SmithKline Beecham Pharmaceuticals, U.S.A.). Stock solutions (50 fAM) of ET-l and sarafotoxin S6c were prepared in 0.1 M acetic acid and dilutions made in 0.9% NaCl solution (saline). Stock solutions (50 AM) of BQ 3020 were prepared in 0.1 M ammonium chloride. BQ-123 and indomethacin were prepared in 100mM Na2CO3 and diluted in saline as required. All other drugs were dissolved in saline. Drugs were kept on ice and protected from light.
Statistical analyses
Differences between treatment means were assessed by analysis of variance followed by a modified t-statistic (Wallenstein et al., 1980) Peripheral lung Figure 3b shows the distribution of autoradiographic grains derived from total ['25I]-ET-l (0.5 nM, 60 min) binding in a frozen section (10Jlm) of ovine peripheral lung tissue. The highest levels of binding were associated with alveolar septae and vascular smooth muscle, with lower levels over bronchial airway smooth muscle. It can. be seen that specific grain density (230 ± 16 grains 1000 gm-2) was markedly reduced over alveolar wall tissue, but not abolished in the presence of the ETA-selective antagonist, BQ 123 (1 gAM; 107 ± 8 grains 1000 gm-2; 53.5% inhibition) alone (Figure 3c ), or the ETB-selective agonist, sarafotoxin S6c (100 nM; 139 ± 8 grains 1000 gm-2; 39.6% inhibition) alone (Figure 3d ). However, binding was reduced to levels approaching background in the combined presence of 1 FM BQ 123 and 100 nM sarafotoxin S6c (non-specific = 8 ± 7 grains 1000 1im2; Figure 3e ). In contrast, the binding associated with bronchial smooth muscle and with vascular smooth muscle, was virtually abolished in the presence of BQ 123 (1 JIM) only (Figure 3c ), but was not markedly altered by 100 nM sarafotoxin S6c (Figure 3d ).
Functional studies
Trachea Carbachol and ET-1 caused concentration-dependent contraction of ovine tracheal smooth muscle preparations. ET-l (pD2 = 8.36 ± 0.06, n = 14) was approximately 35 times more potent than carbachol (pD2 = 6.81 ± 0.07, n = 12; P<0.001), but the maximal contractile response (E..,,) was only 71 ± 6% of that to carbachol (pooled value from data (Figure 8 ; pD2 carbachol = 6.02 ± 0.18; Es. = 15.0 ± 2.1 fold increase above basal; n= 3 experiments). However, the response to ET-1 was variable across the concentration-range tested. The maximum level of (3H]-InsPs accumulated in response to ET-1 was less than 20% of that to carbachol (P< 0.05), while the ETB receptor-selective agonist, sarafotoxin S6c was inactive at all concentrations tested (Figure 8 ).
Discussion
This study has clearly demonstrated that ETA receptors predominate in ovine tracheal smooth muscle and mediate 100-r is consistent with a value of 7.1 in guinea-pig aorta (Hay, 1992) and with its pA2 value of 6.9 in rat thoracic aorta (Sumner et al., 1992) . Furthermore, the ETB receptorselective agonists, sarafotoxin S6c (Williams et al., 1991) and BQ 3020 (Ihara et al., 1992b) were virtually inactive as spasmogens in ovine tracheal smooth muscle preparations. This is consistent with evidence in sheep that ET-1-induced bronchial smooth muscle contraction was mediated via ETA receptors (Noguchi et al., 1992; Abraham et al., 1993) . However, the present data contrast sharply with results obtained in airway smooth muscle from other species. For example, ET-1-induced contraction in guinea-pig bronchus was mediated predominantly via ETB receptors (Hay, 1992) , although evidence for multiple receptor subtypes in this tissue has been reported (Tschirhart et al., 1991) . Furthermore, ETB receptors were also primarily responsible for mediating ET-1-induced contraction in human bronchus (Hay et al., 1993) . However, in rat trachea, both ETA and ET5 receptors coexisted in approximately equal proportions and mediated responses which made approximately equivalent contributions to ET-1-induced increases in airway smooth muscle tone (Henry, 1993) .
Species differences are also apparent with respect to the signal transduction mechanisms to which ET receptor subtypes are linked. In rat tracheal smooth muscle, ET-1-induced contraction mediated via ETA receptors was linked to the phosphoinositide generating pathway, whereas ETB receptors were linked to the influx of extracellular Ca2+ via non L-type Ca2+ channels (Henry, 1993) . In contrast, in the present study, ET-1-induced contraction was completely dependent upon extracellular Ca2+ influx and this response was only partially associated with voltage-dependent L-type Ca2+ channels. Furthermore, the dependence on extracellular Ca2+ influx of ET-1-induced contraction mediated via ETA receptors is consistent with the trivial increases in intracellular inositol phosphate accumulation observed in response to this peptide and to sarafotoxin S6c.
Autoradiographic data showed that a homogeneous population of ETA receptors was also present at sites associated with submucosal glands and in clearly defined blood vessels and the density of these sites was greater than that seen over airway smooth muscle cells. In contrast, ETB receptors were detected in the tracheal wall in association with submucosal cells residing at or near the epithelial basement membrane. The density of these sites was also greater than that for ETA receptors in airway smooth muscle. While the cell type associated with these sites could not be accurately resolved, endothelial cells from the bronchial microcirculation are a likely location of these receptors, since it is established that vascular endothelial cells contain ETB receptors (Masaki et al., 1991; Hirata et al., 1993) . ETB receptors were also detected in ovine lung parenchyma, most noticeably in association with the alveolar wall, where sarafotoxin S6c-sensitive binding accounted for approximately 40% of the specific binding of ['251 ]-ET-1. Almost all of the remaining specific binding was BQ 123-sensitive and was thus defined as ETA receptor-associated. As observed in the trachea, the ETB receptor-selective agonist sarafotoxin S6c abolished ['251 ]-ET-1 binding to cells at or near the epithelial basement membrane in peripheral bronchi. In contrast, BQ 123 abolished bronchial smooth muscle binding, indicating that ETA receptors predominated in ovine peripheral airway smooth muscle, as well as in tracheal airway smooth muscle.
ET-1-induced contraction of ovine peripheral lung strips was also apparently mediated via ETA receptors, since the ETB receptor-selective agonists sarafotoxin S6c and BQ 3020 were virtually inactive as spasmogens in this tissue. The precise locations of all of the ETA receptors mediating contractile responses of ovine lung strips is not known. However, it seems likely that ETA receptors in bronchial smooth muscle mediated a large proportion of the total response. Vascular smooth muscle contraction mediated via ETA receptors may also have contributed to lung strip responses to ET-1, since this tissue component in lung strips has been reported previously to be active in response to spasmogens (Bertram et al., 1983) . It is also possible that some alveolar wall ETA receptors existed in contractile cells such as interstitial myofibroblasts (Kapanci et al., 1974) which may contribute to the increase in lung strip tone in response to ET-1. However, evidence from electron microscopic autoradiography suggests that specific [251I]-ET-1 binding in the alveolar wall primarily involves vascular endothelial cells and fibroblasts (Furuya et al., 1991; 1992) . It seems likely that ovine alveolar ETB receptors reside in capillary endothelial cells (Hirata et al., 1993) and are thus unlikely to contribute to ET-1-induced lung strip contraction.
In conclusion, this study has demonstrated that although both ETA and ETB receptors exist in the ovine respiratory tract, it is the ETA receptor subtype which mediates airway smooth muscle contraction. This contrasts sharply with human airway smooth muscle in which ET-1-induced contraction is mediated primarily via ETB receptors.
